DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine

Runzhang Liang1, Xiaosong Li2, Weiquan Li3

  • 1School of Laboratory Medicine, Hangzhou Medical College, Hangzhou 310053, China; Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Guangdong Medical University, Zhanjiang 524023, China.

Insights

DNA methylation plays a key role in lung cancer development and progression. Advances in DNA methylation detection, particularly through liquid biopsies, are crucial for improving early diagnosis and treatment strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • DNA methylation, the addition of a methyl group to cytosine, is catalyzed by DNA methyltransferases (DNMTs).
  • Altered DNA methylation patterns are implicated in the pathogenesis, progression, and metastasis of lung cancer.
  • Smoking is a known environmental factor that can induce changes in DNA methylation, contributing to lung cancer risk.

Purpose of the Study:

  • To review the multifaceted role of DNA methylation in lung cancer.
  • To highlight recent advancements in understanding DNA methylation's impact on lung cancer.
  • To discuss challenges and future directions for clinical applications of DNA methylation in lung cancer.

Main Methods:

  • Literature review of studies on DNA methylation and lung cancer.
  • Analysis of the mechanisms linking DNA methylation to lung cancer pathogenesis and progression.
  • Evaluation of current diagnostic and therapeutic strategies involving DNA methylation.

Main Results:

  • DNA methylation is integral to lung cancer occurrence, progression, and metastasis.
  • Smoking-induced methylation changes are associated with lung cancer, particularly central types.
  • Current limitations in methylation markers, sample testing, and detection sensitivity hinder clinical utility.

Conclusions:

  • DNA methylation is a critical factor in lung cancer biology.
  • Improving methylation detection sensitivity and specificity, especially in liquid biopsies, is essential for clinical translation.
  • Future research should focus on overcoming current limitations for effective lung cancer management.